Lucentis
Ranibizumab · Genentech, Inc.
PRESCRIPTION ONLY (USA)Lucentis ingredients
| Active ingredient | Strength |
|---|---|
| Ranibizumab | 10 mg/mL, 6 mg/mL |
What Lucentis is used for
Lucentis is a specialist medicine (vascular endothelial growth factor inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Lucentis
- Generic name
- Ranibizumab
- Made by
- Genentech, Inc.
- Forms
- Injection, Solution
- Given
- Intravitreal
- Drug class
- Vascular Endothelial Growth Factor Inhibitor
- FDA approval
- Biologic licence (BLA) BLA125156
- On the US market since
- 2006
Official information
- Lucentis prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Ranibizumab)
In India
- Ranibizumab: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Lucentis?
Lucentis (Ranibizumab) is a specialist medicine made by Genentech, Inc., approved by the US FDA.
What are the ingredients of Lucentis?
Lucentis contains Ranibizumab (10 mg/mL, 6 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA